Provided by Tiger Trade Technology Pte. Ltd.

Hims & Hers Health Inc.

33.78
+1.926.03%
Post-market: 33.73-0.0550-0.16%19:59 EDT
Volume:14.71M
Turnover:492.64M
Market Cap:7.88B
PE:-54.22
High:34.46
Open:31.67
Low:31.60
Close:31.86
52wk High:65.30
52wk Low:13.74
Shares:233.31M
Float Shares:212.45M
Volume Ratio:1.11
T/O Rate:6.92%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-0.6230
EPS(LYR):0.5123
ROE:-32.03%
ROA:-2.21%
PB:24.32
PE(LYR):65.94

Loading ...

Movement Alert|Hims & Hers Health Declines 5.3% in Regular Trading, Trading at $36.04

Market Focus
·
Jul 16

Movement Alert|Hims & Hers Health Rises 5.26% in Regular Trading, Trading at $36.85

Market Focus
·
Jul 15

Press Release: Hims & Hers to Announce Second Quarter 2026 Financial Results on August 10, 2026

Dow Jones
·
Jul 14

Hims & Hers Sets Second-quarter Results Release and Investor Call

Reuters
·
Jul 14

Movement Alert|Hims & Hers Health Falls 5.36% in Regular Trading, Insider Selling Filings Add to Ongoing Fundamental Pressure

Market Focus
·
Jul 10

Hims & Hers's Peptide Opportunity Remains in Focus

Dow Jones
·
Jul 10

Hims & Hers Health is Maintained at Neutral by B of a Securities

Dow Jones
·
Jul 09

Analysts’ Opinions Are Mixed on These Healthcare Stocks: Hims & Hers Health (HIMS) and Tarsus Pharmaceuticals (TARS)

TIPRANKS
·
Jul 09

Movement Alert|Hims & Hers Health Falls 5.11% in Regular Trading, Trading at $34.26

Market Focus
·
Jul 08

Movement Alert|Hims & Hers Health Falls 5.2% in Pre-Market Trading, Trading at $34.45

Market Focus
·
Jul 08

Hims & Hers CFO Oluyemi Okupe Disposes of 7,163 Common Shares for $261,540.56

Reuters
·
Jul 08

Movement Alert|Hims & Hers Health Declines 5.02% in Regular Trading, Trading at $36.33

Market Focus
·
Jul 08

Movement Alert|Hims & Hers Health Rises 5.14% in Regular Trading, Continued Momentum Following BofA Price Target Upgrade

Market Focus
·
Jul 06

Trump's FDA May Soon Throw Its Weight Behind Peptides. Should You Buy In?

Dow Jones
·
Jul 05

Hims & Hers Health (HIMS) Secures $400 Million Financing, Is The Upside Already Priced In?

Simply Wall St.
·
Jul 02

Hims & Hers Health - Receivables Purchase Agreement Has Initial 364-day Term, Extendable by Written Agreement - SEC Filing

THOMSON REUTERS
·
Jul 02

Hims & Hers Signs USD 400 Million Receivables Purchase Facility with Jpmorgan Chase

Reuters
·
Jul 02

Sector Update: Healthcare

MT Newswires Live
·
Jul 02

Movement Alert|Hims & Hers Health Rises 5.12% in Regular Trading, BofA Securities Raises Price Target to $36 From $25

Market Focus
·
Jul 01

BofA Securities Adjusts Hims & Hers Health Price Target to $36 From $25, Maintains Neutral Rating

MT Newswires Live
·
Jul 01